SAC Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,375	Closed	-$309K	–	542
2014 Q1	$309K	Buy	+7,375	New	+$309K	﹤0.01%	1327
2013 Q3	–	Sell	-508,311	Closed	-$11.9M	–	1773
2013 Q2	$11.9M	Buy	+508,311	New	+$11.9M	0.07%	307